# RhinoCyte

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rhinocyte

- Industry: Biotechnology
- Headquarters: Louisville, US
- Website: www.rhinocyte.com
- Total disclosed funding: $2.2M
- Latest round: Series A (Jul 8, 2014)
- Investors on record: 3

## About

Based in the US, RhinoCyte Inc. develops a breakthrough technology engages in the development and commercialization of diagnostic tools and therapies for stem cell treatment of multiple degenerative and traumatic neurological diseases.

## Funding rounds

- Series A, Jul 8, 2014, $0.6M — Kentucky Seed Capital Fund
- Series A, Aug 7, 2006, $1.6M — Queen City Angels, Kentucky Seed Capital Fund, Kentucky Science and Technology Corporation

## Investors

- Queen City Angels (https://capitalatlas.ai/funds/queen-city-angels) — Series A
- Kentucky Seed Capital Fund (https://capitalatlas.ai/funds/kentucky-seed-capital-fund) — Series A
- Kentucky Science and Technology Corporation — Series A